Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression
    Published on 2024-09-06
    1 year ago
  • Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility
    Published on 2024-09-06
    1 year ago
  • Revisiting the role of computational neuroimaging in the era of integrative neuroscience
    Published on 2024-09-06
    1 year ago
  • Prenatal exposure to the mineralocorticoid receptor antagonist spironolactone disrupts hippocampal area CA2 connectivity and alters behavior in mice
    Published on 2024-09-05
    1 year ago
  • GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: insights from an operant meal schedule paradigm
    Published on 2024-09-04
    1 year ago
  • Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome
    Published on 2024-09-02
    1 year ago
  • Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia
    Published on 2024-08-31
    1 year ago
« Previous 1 … 43 44 45 46 47 … 143 Next »
Journal of Psychopharmacology
  • Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase
    Published on 2023-08-18
    2 years ago
  • Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study
    Published on 2023-08-17
    2 years ago
  • The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
    Published on 2023-08-12
    2 years ago
  • Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study
    Published on 2023-08-04
    2 years ago
  • QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors
    Published on 2023-08-03
    2 years ago
  • Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users
    Published on 2023-08-02
    2 years ago
  • Ketamine: A new chapter for clinical psychopharmacology?
    Published on 2023-08-01
    2 years ago
« Previous 1 … 43 44 45 46 47 … 134 Next »
European Neuropsychopharmacology
  • Psychomotor slowing in schizophrenia is associated with cortical thinning of primary motor cortex: A three cohort structural magnetic resonance imaging study
    Published on 2023-09-16
    2 years ago
  • Is it stress or is it the hormones? Perinatal depression in fathers
    Published on 2023-09-12
    2 years ago
  • A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity in healthy young men
    Published on 2023-09-04
    2 years ago
  • Exploring the potential of Esketamine in the treatment of bipolar depression
    Published on 2023-09-04
    2 years ago
  • The prevalence and correlates of suicidal ideation in Chinese psychiatric patients during the fifth wave of COVID-19 in Hong Kong
    Published on 2023-09-02
    2 years ago
  • Social cognition and psychosocial functioning in schizophrenia and bipolar disorder: Theory of mind as a key to understand schizophrenia dysfunction
    Published on 2023-09-02
    2 years ago
  • Controversies about ADHD: Early or also late-onset? Neurodevelopmental or also stress-related?
    Published on 2023-09-01
    2 years ago
« Previous 1 … 43 44 45 46 47 … 153 Next »

   Pharma Pub